Pulmonx Corp (NAS:LUNG)
$ 8.07 -0.31 (-3.7%) Market Cap: 313.24 Mil Enterprise Value: 237.69 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 61/100

Pulmonx Corp at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 03:00PM GMT
Release Date Price: $40.35 (+2.59%)
Robert Adam Hopkins
BofA Securities, Research Division - MD of Equity Research

Okay. Great. Thanks, everybody, for joining us for the next fireside chat here. As a reminder, I'm Bob Hopkins from Bank of America on the medical device side. Also here with Clay DeMarcus, who works on my team, and we're really excited for the next fireside chat. Pulmonx, I think everybody knows. We have Glen French, the company's Chief Executive Officer; and Derrick Sung, the company's Chief Financial Officer.

We're going to have -- I'm going to hand it over to Glen to make a quick introductory a couple of comments, and then we'll fire away with questions. So Glen, Derrick, thanks very much for being here. And Glen, I'll hand it over to you.

Glendon E. French
Pulmonx Corporation - CEO, President & Director

Great. Thanks, Bob and Clay. Really appreciate the opportunity and look forward -- I'm really looking forward to this. I just wanted to say that we are -- boy, it's so refreshing to look up on the horizon and not see this COVID cloud building. And nothing will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot